Why the study?
How do serum concentrations of digitoxin and digoxin vary day-to-day in patients on maintenance therapy?
How do serum concentrations of digitoxin and digoxin vary day-to-day in patients on maintenance therapy?
Digitoxin exhibits less day-to-day serum concentration variability than digoxin, and its levels are dependent on serum albumin concentrations.
Answers are grounded in this paper and cite their sources.
Digitoxin may yield steadier serum levels than digoxin on maintenance therapy; leaves open outcome impact and needs prospective validation.
Serum concentrations of digitoxin and digoxin were measured in 145 cases with various heart diseases receiving maintenance doses of digitalis. Digitalis toxicity was seen in only 2 cases (1.4%). Day-to-day variation of serum concentration while taking the same daily dose was small in digitoxin therapy (13.8%), but a considerable variation was seen in digoxin therapy (24.4%). Serum concentrations of both digitoxin and digoxin were measured in the patients receiving digitoxin, and there was a positive correlation between the two (r = 0.66, p less than 0.001). This fact suggested that the effect of digitoxin was the sum of the effects of digitoxin and its metabolite, digoxin. In the patients taking digoxin, digitoxin was not detected in the serum. Serum digitoxin level had a significantly positive correlation to serum albumin level, presumably because digitoxin was retained in serum in the bound form to albumin. Minimal effective level, 10 ng/ml, was however obtained with higher daily dose of digitoxin in patients with lower serum albumin.
No takes yet. Share an insight, caveat, or question.
Takahashi et al. (1979) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: